Androgen Deprivation Therapy in High-Risk Prostate Cancer

被引：0
|
作者：
Buyyounouski, Mark K. [1 ]
机构：
[1] Fox Chase Canc Ctr, Dept Radiat Oncol, Philadelphia, PA 19111 USA
来源：
ONCOLOGY-NEW YORK | 2010年 / 24卷 / 09期
关键词：
RADIOTHERAPY;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：806 / 809
页数：2
相关论文
共 50 条
  • [1] Androgen Deprivation Therapy in High-Risk Localized and Locally Advanced Prostate Cancer
    Iwamoto, Hiroaki
    Izumi, Kouji
    Makino, Tomoyuki
    Mizokami, Atsushi
    CANCERS, 2022, 14 (07)
  • [2] Androgen deprivation therapy in high risk prostate cancer
    Van Dams, Ritchell
    Kishan, Amar U.
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (05) : 2216 - 2217
  • [3] Hypofractionated radiation therapy combined with androgen deprivation therapy for high-risk localized prostate cancer
    Lee, Tae Hoon
    Pyo, Hongryull
    Yoo, Gyu Sang
    Jeon, Seong Soo
    Seo, Seong Il
    Jeong, Byong Chang
    Jeon, Hwang Gyun
    Sung, Hyun Hwan
    Kang, Minyong
    Song, Wan
    Chung, Jae Hoon
    Bae, Bong Kyung
    Park, Won
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2024, 68 (03) : 333 - 341
  • [4] Eighteen Months of Androgen Deprivation Therapy in Men with High-risk Prostate Cancer and the Risk of Death
    Xie, Wanling
    D'Amico, Anthony V.
    EUROPEAN UROLOGY, 2018, 74 (04) : 442 - 443
  • [5] Duration of androgen deprivation therapy in high-risk prostate cancer: A randomized trial.
    Nabid, Abdenour
    Carrier, Nathalie
    Martin, Andre-Guy
    Bahary, Jean-Paul
    Souhami, Luis
    Duclos, Marie
    Vincent, Francois
    Vass, Sylvie
    Bahoric, Boris
    Archambault, Robert
    Lemaire, Celine
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (18)
  • [6] Duration of androgen deprivation therapy in high-risk prostate cancer: A randomized trial.
    Nabid, Abdenour
    Carrier, Nathalie
    Martin, Andre-Guy
    Bahary, Jean-Paul
    Souhami, Luis
    Duclos, Marie
    Vincent, Francois
    Vass, Sylvie
    Bahoric, Boris
    Archambault, Robert
    Lemaire, Celine
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Androgen Deprivation Therapy: A Survival Benefit or Detriment in Men With High-Risk Prostate Cancer?
    Fang, L. Christine
    Merrick, Gregory S.
    Wallner, Kent E.
    ONCOLOGY-NEW YORK, 2010, 24 (09): : 790 - 797
  • [8] Influences on androgen deprivation therapy prescribing before surgery in high-risk prostate cancer
    Dunsmore, Jennifer
    Duncan, Eilidh
    Maclennan, Sara J.
    N'Dow, James
    Cornford, Philip
    Esperto, Francesco
    Pavan, Nicola
    Ribal, Maria J.
    Roobol, Monique J.
    Skolarus, Ted A.
    Maclennan, Steven
    BJUI COMPASS, 2024, 5 (09): : 874 - 884
  • [9] Androgen deprivation therapy in combination with radiotherapy for high-risk clinically localized prostate cancer
    Nishiyama, Tsutomu
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2012, 129 (3-5): : 179 - 190
  • [10] The curative effect of androgen deprivation therapy alone is insufficient in high-risk prostate cancer
    Choi, Se Young
    Lim, Bumjin
    Chi, Byung Hoon
    Lee, Wonchul
    Kim, Jung Hoon
    Kyung, Yoon Soo
    You, Dalsan
    Kim, Choung-Soo
    MEDICINE, 2021, 100 (31) : E26833
12345